Skip to main content
logo
Neovacs S.A. (EPA:ALNEV)
France flag France · Delayed Price · Currency is EUR
0.0799
-0.0065 (-7.52%)
Nov 10, 2026, 3:03 PM CET

Neovacs Financials Overview

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.810.40.430.5300.02
Revenue Growth
102.04%-7.59%-18.65%47868.71%-95.07%-24.32%
Gross Profit
-1.85-2.27-2.77-3.47-3.4-4.54
Operating Income
-4.81-5.35-6.62-6.91-6.44-7.83
Net Income
-4.09-4.9-32.91-8.74-3.55-11.84
Earnings Per Share
-----0.01-5.95
EPS Growth
------

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.010.570.440.896.7633.09
Total Debt
0.70.540.230.651.21.03
Net Cash (Debt)
-0.70.030.210.245.5532.06
Net Cash Growth
--83.31%-13.29%-95.74%-82.67%231.12%
Net Cash Per Share
----0.0216.10

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-4.16-5.03-3.6-1.91-4.45-9.91
Capital Expenditures
-0-0.01-0.08-0.2-0.15-0.35
Free Cash Flow
-4.17-5.04-3.68-2.12-4.6-10.26
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Margin
-593.40%-1334.11%-1525.96%-1294.97%-579583.27%-34725.65%
Pretax Margin
-557.51%-1377.91%-7823.36%-1803.52%-390822.21%-55356.01%
Profit Margin
-504.93%-1221.13%-7585.07%-1639.15%-319109.98%-52512.21%
FCF Margin
-514.44%-1256.72%-848.26%-396.80%-413782.37%-45498.69%

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-00000
PS Ratio
0.020.01----